343 related articles for article (PubMed ID: 27296000)
1. [Expression of microRNA let-7a, miR-155, and miR-205 in tumor and tumor-adjacent histologically normal tissue in patients with non-small cell lung cancer].
Shikeeva AA; Kekeeva TV; Zavalishina LE; Andreeva YY; Zaletaev DV; Frank GA
Arkh Patol; 2016; 78(3):3-10. PubMed ID: 27296000
[TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of let-7a miRNA in the blood of non-small cell lung cancer patients.
Jeong HC; Kim EK; Lee JH; Lee JM; Yoo HN; Kim JK
Mol Med Rep; 2011; 4(2):383-7. PubMed ID: 21468581
[TBL] [Abstract][Full Text] [Related]
3. Use of microRNA expression levels to predict outcomes in resected stage I non-small cell lung cancer.
Duncavage E; Goodgame B; Sezhiyan A; Govindan R; Pfeifer J
J Thorac Oncol; 2010 Nov; 5(11):1755-63. PubMed ID: 20975375
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC).
Zhang JG; Wang JJ; Zhao F; Liu Q; Jiang K; Yang GH
Clin Chim Acta; 2010 Jun; 411(11-12):846-52. PubMed ID: 20223231
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-383 is a tumor suppressor and potential prognostic biomarker in human non-small cell lung caner.
Shang Y; Zang A; Li J; Jia Y; Li X; Zhang L; Huo R; Yang J; Feng J; Ge K; Yang Y; Zhang Y; Jiang J
Biomed Pharmacother; 2016 Oct; 83():1175-1181. PubMed ID: 27551765
[TBL] [Abstract][Full Text] [Related]
6. An assessment of the relationship between the expression of CCR7/CCL19 axis and selected regulatory miRNAs in non-small cell lung cancer.
Baran K; Kiszałkiewicz J; Migdalska-Sęk M; Jabłoński S; Kordiak J; Antczak A; Góralska K; Brzeziańska-Lasota E
Mol Biol Rep; 2019 Oct; 46(5):5389-5396. PubMed ID: 31463641
[TBL] [Abstract][Full Text] [Related]
7. DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: implications for outcomes and histologic classification.
Díaz-García CV; Agudo-López A; Pérez C; López-Martín JA; Rodríguez-Peralto JL; de Castro J; Cortijo A; Martínez-Villanueva M; Iglesias L; García-Carbonero R; Fresno Vara JA; Gámez-Pozo A; Palacios J; Cortés-Funes H; Paz-Ares L; Agulló-Ortuño MT
Carcinogenesis; 2013 May; 34(5):1031-8. PubMed ID: 23349018
[TBL] [Abstract][Full Text] [Related]
8. Let-7g and miR-21 expression in non-small cell lung cancer: correlation with clinicopathological and molecular features.
Capodanno A; Boldrini L; Proietti A; Alì G; Pelliccioni S; Niccoli C; D'Incecco A; Cappuzzo F; Chella A; Lucchi M; Mussi A; Fontanini G
Int J Oncol; 2013 Sep; 43(3):765-74. PubMed ID: 23820752
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-34b functions as a tumor suppressor and acts as a nodal point in the feedback loop with Met.
Wang LG; Ni Y; Su BH; Mu XR; Shen HC; Du JJ
Int J Oncol; 2013 Mar; 42(3):957-62. PubMed ID: 23314612
[TBL] [Abstract][Full Text] [Related]
10. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E
Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406
[TBL] [Abstract][Full Text] [Related]
11. lncRNA NEAT1 competes against let-7a to contribute to non-small cell lung cancer proliferation and metastasis.
Qi L; Liu F; Zhang F; Zhang S; Lv L; Bi Y; Yu Y
Biomed Pharmacother; 2018 Jul; 103():1507-1515. PubMed ID: 29864936
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-184 Deregulated by the MicroRNA-21 Promotes Tumor Malignancy and Poor Outcomes in Non-small Cell Lung Cancer via Targeting CDC25A and c-Myc.
Lin TC; Lin PL; Cheng YW; Wu TC; Chou MC; Chen CY; Lee H
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1532-9. PubMed ID: 25990966
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of miR-125a-5p and let-7e predicts the progression and prognosis of non-small cell lung cancer.
Zhu WY; Luo B; An JY; He JY; Chen DD; Xu LY; Huang YY; Liu XG; Le HB; Zhang YK
Cancer Invest; 2014 Oct; 32(8):394-401. PubMed ID: 24945821
[TBL] [Abstract][Full Text] [Related]
14. Association of long non-coding RNA H19 and microRNA-21 expression with the biological features and prognosis of non-small cell lung cancer.
Zhou Y; Sheng B; Xia Q; Guan X; Zhang Y
Cancer Gene Ther; 2017 Aug; 24(8):317-324. PubMed ID: 28799568
[TBL] [Abstract][Full Text] [Related]
15. The pri-let-7a-2 rs1143770C>T is associated with prognosis of surgically resected non-small cell lung cancer.
Shin KM; Jung DK; Hong MJ; Kang HJ; Lee WK; Yoo SS; Lee SY; Cha SI; Lee J; Kim CH; Seok Y; Cho S; Son JW; Lee EB; Jheon S; Kim YT; Park JY
Gene; 2016 Feb; 577(2):148-52. PubMed ID: 26625972
[TBL] [Abstract][Full Text] [Related]
16. Expression of miRNAs in non-small-cell lung carcinomas and their association with clinicopathological features.
Tafsiri E; Darbouy M; Shadmehr MB; Zagryazhskaya A; Alizadeh J; Karimipoor M
Tumour Biol; 2015 Mar; 36(3):1603-12. PubMed ID: 25384507
[TBL] [Abstract][Full Text] [Related]
17. Associations of deregulation of mir-365 and its target mRNA TTF-1 and survival in patients with NSCLC.
Sun R; Liu Z; Ma G; Lv W; Zhao X; Lei G; Xu C
Int J Clin Exp Pathol; 2015; 8(3):2392-9. PubMed ID: 26045746
[TBL] [Abstract][Full Text] [Related]
18. A mathematical model for microRNA in lung cancer.
Kang HW; Crawford M; Fabbri M; Nuovo G; Garofalo M; Nana-Sinkam SP; Friedman A
PLoS One; 2013; 8(1):e53663. PubMed ID: 23365639
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-153 expression and prognosis in non-small cell lung cancer.
Chen WJ; Zhang EN; Zhong ZK; Jiang MZ; Yang XF; Zhou DM; Wang XW
Int J Clin Exp Pathol; 2015; 8(7):8671-5. PubMed ID: 26339455
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA let-7a inhibits the proliferation and invasion of nonsmall cell lung cancer cell line 95D by regulating K-Ras and HMGA2 gene expression.
Wang YY; Ren T; Cai YY; He XY
Cancer Biother Radiopharm; 2013 Mar; 28(2):131-7. PubMed ID: 23134218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
